19 Participants Needed

Lovaza + Curcumin for Lung Nodule Reduction

JG
MS
FK
MA
DK
NK
LR
Overseen ByLary Robinson, MD
Age: 18+
Sex: Any
Trial Phase: Phase 2
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

Trial Summary

What is the purpose of this trial?

The purpose of this study is to find out if an investigational combination drug called Lovaza (made with fish oils)+Curcumin C3 Complex (made from a root called curcumin) can help reduce the size of lung nodules. Researchers also want to find out if the combination of Lovaza+Curcumin C3 Complex is safe and tolerable.

Will I have to stop taking my current medications?

The trial requires participants to stop taking any current vitamin or mineral supplements that contain components of the study agents. A standard multivitamin will be provided for the study. The protocol does not specify if you need to stop other medications, so it's best to discuss this with the trial team.

What evidence supports the effectiveness of the drug Lovaza + Curcumin for lung nodule reduction?

Curcumin, a component of the treatment, has shown potential in reducing inflammation and has been studied for its effects on lung cancer, suggesting it might help with lung-related conditions. However, most evidence comes from laboratory or animal studies, and its effectiveness in humans, especially for lung nodules, is not well-established.12345

Is the combination of Lovaza and Curcumin generally safe for humans?

Curcumin is considered generally safe by the US FDA, but it may increase lung tumor growth and inflammation in certain conditions, particularly in smokers or ex-smokers. Additionally, curcumin has shown little toxicity to normal tissues in combination with other treatments in some studies.678910

How is the drug Lovaza + Curcumin unique for lung nodule reduction?

The combination of Lovaza (an omega-3 fatty acid) and Curcumin (a compound from turmeric) is unique because it targets lung nodules with both anti-inflammatory and potential anti-tumor effects, leveraging Curcumin's ability to affect cancer cell pathways and enhance chemotherapy, while Lovaza may support overall health with its omega-3 content.258911

Research Team

NK

Nagi Kumar, PhD

Principal Investigator

H. Lee Moffitt Cancer Center and Research Institute

Eligibility Criteria

This trial is for current or former smokers aged 55+ with a history of heavy smoking (≥20 pack years), who have certain types of lung nodules detected on CT scans. Participants must be able to swallow pills, undergo CT scans, and willing to stop taking any vitamin/mineral supplements that overlap with the study drugs.

Inclusion Criteria

My organs and bone marrow are functioning normally.
I am fully active or can carry out light work.
I am 55 years old or older.
See 11 more

Exclusion Criteria

I was diagnosed with invasive cancer, other than skin cancer, in the last 2 years.
I am not pregnant or breastfeeding.
You have a newly discovered lung nodule that meets specific size and shape criteria.
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive Lovaza and Curcumin C3 Complex or placebo for 6 months to assess reduction in lung nodule size and safety

6 months

Follow-up

Participants are monitored for safety and effectiveness after treatment

7 months

Treatment Details

Interventions

  • Curcumin C3 complex
  • Lovaza
  • Placebo
Trial Overview Researchers are testing if Lovaza (fish oil) combined with Curcumin C3 Complex can reduce the size of lung nodules in smokers. The safety and tolerability of this drug combination are also being evaluated in this phase II trial.
Participant Groups
3Treatment groups
Active Control
Group I: Curcumin C3 complex® +Lovaza® +PlaceboActive Control3 Interventions
Group B: 2 grams Lovaza®, 1 gram twice a day, AM and PM. 4,000 mgs CUR Curcumin C3 complex® tablets, 2,000 mgs twice a day, AM and PM. 1 placebo capsule twice a day, AM and PM.
Group II: Curcumin C3 complex® +Lovaza®Active Control2 Interventions
Group A: 4 grams Lovaza®, 2 grams twice a day (BID). 2 grams by mouth daily, AM and PM 8,000 mgs CUR Curcumin C3 complex® tablets, divided into 2 doses. 4 grams by mouth, twice a day, AM and PM.
Group III: Placebo onlyActive Control1 Intervention
Placebo: Two matching placebo capsules twice a day (BID), taken by mouth, AM and PM

Curcumin C3 complex is already approved in United States, European Union, Canada, India for the following indications:

🇺🇸
Approved in United States as Curcumin C3 Complex for:
  • Dietary Supplement
  • Antioxidant
🇪🇺
Approved in European Union as Curcumin C3 Complex for:
  • Food Supplement
  • Antioxidant
🇨🇦
Approved in Canada as Curcumin C3 Complex for:
  • Natural Health Product
  • Antioxidant
🇮🇳
Approved in India as Curcumin C3 Complex for:
  • Ayurvedic Medicine
  • Antioxidant

Find a Clinic Near You

Who Is Running the Clinical Trial?

H. Lee Moffitt Cancer Center and Research Institute

Lead Sponsor

Trials
576
Recruited
145,000+

James and Esther King Biomedical Research Program

Collaborator

Trials
15
Recruited
2,200+

Findings from Research

Curcumin, a compound found in turmeric, has shown potential therapeutic effects in treating pulmonary diseases by regulating key inflammatory factors, but most evidence comes from in vitro or animal studies rather than human trials.
The main challenge in using curcumin for treatment is its poor bioavailability, which may require the use of adjuvants or specialized delivery methods like nanoparticles to enhance its effectiveness in humans.
Curcumin use in pulmonary diseases: State of the art and future perspectives.Lelli, D., Sahebkar, A., Johnston, TP., et al.[2018]
Curcumin, a natural compound from turmeric, shows significant antitumor activity against lung cancer by targeting multiple molecular pathways, including those involved in cell growth and survival, which can help reduce cancer cell viability and proliferation.
Curcumin not only enhances the effectiveness of chemotherapy and radiotherapy in lung cancer treatment but also improves the bioavailability of curcumin through nanocarriers, making it a promising adjunct therapy in cancer management.
Versatile role of curcumin and its derivatives in lung cancer therapy.Ashrafizadeh, M., Najafi, M., Makvandi, P., et al.[2021]
Curcumin, a natural anti-inflammatory compound, has demonstrated efficacy in treating various chronic conditions, including rheumatoid arthritis, inflammatory bowel disease, and several types of cancer, based on numerous experimental and pharmacologic trials.
Despite its potential benefits, there are existing gaps in research and application that have limited the widespread use of curcumin in the medical community, highlighting the need for further investigation into its therapeutic use.
Curcumin: An age-old anti-inflammatory and anti-neoplastic agent.Fadus, MC., Lau, C., Bikhchandani, J., et al.[2023]

References

Curcumin use in pulmonary diseases: State of the art and future perspectives. [2018]
Versatile role of curcumin and its derivatives in lung cancer therapy. [2021]
Curcumin: An age-old anti-inflammatory and anti-neoplastic agent. [2023]
Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study. [2018]
Translating curcumin to the clinic for lung cancer prevention: evaluation of the preclinical evidence for its utility in primary, secondary, and tertiary prevention strategies. [2022]
6.United Arab Emiratespubmed.ncbi.nlm.nih.gov
Quercetin-Decorated Curcumin Liposome Design for Cancer Therapy: In-Vitro and In-Vivo Studies. [2018]
Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats. [2019]
Curcumin as an inhibitor of cancer. [2013]
Lung tumor promotion by curcumin. [2021]
Synergistic antitumor efficiency of docetaxel and curcumin against lung cancer. [2022]
[Preventive role of curcumin in lung cancer]. [2013]